Italia markets closed
FTSE MIB
33.154,05 -32,84 (-0,10%) Dow Jones
39.118,86 -45,20 (-0,12%) Nasdaq
17.732,60 -126,08 (-0,71%) Nikkei 225
39.583,08 +241,54 (+0,61%) Petrolio
81,46 -0,28 (-0,34%) Bitcoin EUR
56.267,64 -1.206,07 (-2,10%)
HRMY Jul 2024 17.500 put
OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a watchlist
In data: 10:51AM EDT. Mercato aperto.
| Chiusura precedente | 0,3100 |
| Aperto | 0,3100 |
| Denaro | 0,0000 |
| Domanda | 0,0000 |
| Prezzo d'esercizio | 17,50 |
| Scadenza | 2024-07-19 |
| Min-Max giorno | 0,3100 - 0,3100 |
| Contratto - Min-Max | N/D |
| Volume | |
| Open Interest | 8 |
GlobeNewswireHarmony Biosciences Reports Second Quarter 2023 Financial Results and Business Updates
WAKIX® (pitolisant) Net Revenue Increased ~25% Year-over-Year to $134.2 Million for Second Quarter 2023 Average Number of Patients on WAKIX Increased by ~350 Sequentially to ~5,450 for Second Quarter 2023 Exited Second Quarter 2023 With ~5,600 Patients on WAKIX Completed Enrollment in Phase 3 Idiopathic Hypersomnia (IH) INTUNE Study; On-track for Topline Data in Fourth Quarter 2023 Plans to Initiate Prader-Willi Syndrome (PWS) Phase 3 Study in Fourth Quarter 2023 Board of Directors Authorized $1
© 2024 Yahoo. Tutti i diritti riservati.